SIGNAL // LOADING
Loading page
Glossary term
Compounded GLP-1
Also known as Compounded semaglutide - Compounded tirzepatide
Semaglutide or tirzepatide compounded at a 503A or 503B pharmacy. Regulated by state boards, not FDA.
Compounded GLP-1 refers to semaglutide or tirzepatide prepared at a licensed compounding pharmacy. It is not FDA-reviewed for efficacy, though the active ingredient is the same pharmaceutical-grade peptide. Availability and legality shift based on FDA shortage status and state-level compounding rules. Compounded versions often cost 40-70% less than branded, which makes them a reasonable off-ramp when insurance denies Wegovy, Ozempic, Mounjaro, or Zepbound. ALUKARD discloses source pharmacy, DEA registration, and testing posture upfront.
Medically reviewed byDr. Lena Okafor, MD
Medical Director - updated April 2026How we review
External references
Related
Connected context
Related terms
Related guides
GLP-1 eligibility explained: who qualifies, who doesn't, and whyTirzepatide vs semaglutide: how to think about the choiceWhat a comprehensive metabolic panel actually tells youProvider-reviewed care vs DIY supplementation: when each makes sensePCOS labs: the markers that actually drive the planGLP-1 side effects: what's normal, what needs review, what stops the protocolHolding the loss after GLP-1: protein, training, and the maintenance planFasting insulin and HOMA-IR: the metabolic signal that precedes A1c by yearsCreatine, protein, and the two supplements that actually moved your labsWeight-loss plateaus on GLP-1: what to change first